Literature DB >> 32956212

Assessment of Alternative Personal Protective Equipment by Emergency Department Personnel During the SARS-CoV-2 Pandemic: A Simulation-Based Pilot Study.

Danielle Shavit1, Oren Feldman, Khetam Hussein, Michal Meir, Asaf Miller, Amichai Gutgold, Ravit Idelman, Noa Kvatinsky, Daniel M Cohen, Itai Shavit.   

Abstract

STATEMENT: Shortage of personal protective equipment (PPE) for frontline healthcare workers managing the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is a major, global challenge. In this pilot study, we describe a simulation-based method for evaluating the suitability and acceptability of an alternative biological isolation garment (BIG, a gown or a suit) for clinical use by emergency department (ED) personnel. Using a high-fidelity simulator, participants provided airway management according to the SARS-CoV-2 protocol. A nonvisible fluorescent marker was used as a surrogate marker of contamination. We assessed ultraviolet light visualization of the fluorescent marker after doffing and satisfaction with donning, use during simulation, and doffing. We found that after doffing, markers were not visualized on any of the participants and that the median satisfaction scores of the alternative and standard BIG (sBIG) were 4 [interquartile range (IQR) = 1-5] and 4 (IQR = 2-4), respectively. The results suggest the suitability and acceptability of the alternative BIG (aBIG) for use by ED personnel.

Entities:  

Mesh:

Year:  2020        PMID: 32956212     DOI: 10.1097/SIH.0000000000000508

Source DB:  PubMed          Journal:  Simul Healthc        ISSN: 1559-2332            Impact factor:   1.929


  1 in total

1.  Development of a Mannequin for Simulation-Based Trials Involving Respiratory Viral Spread During Respiratory Arrest and Cardiopulmonary Arrest Scenarios.

Authors:  Cindy Luu; Margaux Chan; Leo Langga; Elizabeth Bragg; Alyssa Rake; Caulette Young; Jennifer Lau; Edward Guerrero; Joshua Buan; Todd Chang
Journal:  Cureus       Date:  2021-12-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.